BioSyent, Inc. (RX.V)
15.73
-0.33
(-2.05%)
CAD |
TSXV |
Sep 18, 16:00
BioSyent Price : 15.73 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 16.18 | 16.18 | 15.73 | 15.73 | 427.00 |
| Sep 17, 2026 | 16.09 | 16.12 | 16.06 | 16.06 | 2673.00 |
| Sep 16, 2026 | 15.97 | 16.08 | 15.70 | 16.08 | 99233.00 |
| Sep 15, 2026 | 15.84 | 15.98 | 15.77 | 15.98 | 5000.00 |
| Sep 14, 2026 | 15.65 | 15.98 | 15.65 | 15.85 | 2046.00 |
| Sep 11, 2026 | 15.56 | 15.70 | 15.56 | 15.66 | 4555.00 |
| Sep 10, 2026 | 15.69 | 15.69 | 15.64 | 15.65 | 4430.00 |
| Sep 09, 2026 | 15.85 | 15.85 | 15.59 | 15.69 | 5326.00 |
| Sep 08, 2026 | 16.03 | 16.03 | 15.85 | 15.85 | 2240.00 |
| Sep 04, 2026 | 16.03 | 16.03 | 15.87 | 15.97 | 4234.00 |
| Sep 03, 2026 | 16.04 | 16.04 | 15.88 | 15.88 | 2406.00 |
| Sep 02, 2026 | 15.87 | 16.00 | 15.87 | 16.00 | 200.00 |
| Sep 01, 2026 | 16.00 | 16.25 | 15.82 | 15.87 | 7395.00 |
| Aug 31, 2026 | 15.98 | 16.00 | 15.50 | 15.99 | 21010.00 |
| Aug 28, 2026 | 16.00 | 16.00 | 15.75 | 15.75 | 34658.00 |
| Aug 27, 2026 | 15.99 | 16.00 | 15.89 | 15.95 | 10858.00 |
| Aug 26, 2026 | 15.96 | 15.96 | 15.55 | 15.84 | 11031.00 |
| Aug 25, 2026 | 15.59 | 15.75 | 15.59 | 15.70 | 5285.00 |
| Aug 24, 2026 | 15.75 | 15.75 | 15.50 | 15.50 | 8349.00 |
| Aug 21, 2026 | 15.45 | 15.70 | 15.30 | 15.70 | 9130.00 |
| Aug 20, 2026 | 14.75 | 14.75 | 14.75 | 14.75 | 75.00 |
| Aug 19, 2026 | 14.79 | 15.01 | 14.75 | 14.75 | 2403.00 |
| Aug 18, 2026 | 14.65 | 14.70 | 14.60 | 14.60 | 2367.00 |
| Aug 17, 2026 | 15.01 | 15.01 | 14.60 | 14.60 | 7187.00 |
| Aug 14, 2026 | 15.25 | 15.25 | 15.20 | 15.25 | 385.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.91 |
| Bausch Health Cos., Inc. | 7.92 |
| Cipher Pharmaceuticals, Inc. | 14.67 |
| Revive Therapeutics Ltd. | 0.02 |
| Knight Therapeutics, Inc. | 10.25 |
Price Related Metrics
| PE Ratio | 18.35 |
| PS Ratio | 3.249 |
| PEG Ratio | 0.925 |
| Price to Book Value | 3.891 |
| Price to Free Cash Flow | 15.55 |
| Earnings Yield | 5.45% |
| Market Cap | 178.38M |
| PEGY Ratio | 0.8654 |
| Operating PE Ratio | 14.02 |
| Normalized PE Ratio | 18.35 |